MMP24OS: A Drug Target / Disease Biomarker (G101410538)

Target Name: MMP24OS

NCBI ID: G101410538

MMP24OS

Other Name(s): MMP24 antisense RNA 1 | MMP24 opposite strand | MMP24-AS1 | MMP24 opposite strand, transcript variant 1 | MMP24OS variant 1

MMP24OS: A Drug Target / Disease Biomarker

MMP24OS is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscle. It is a member of the integrin family of proteins, which are involved in cell-cell and cell-extracellular matrix interactions. MMP24OS has been shown to play a role in several cellular processes, including cell adhesion, migration, and invasion.

One of the most promising aspects of MMP24OS is its potential as a drug target. Several studies have shown that MMP24OS is highly expressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, MMP24OS has been shown to interact with several drug targets, including TGF-β1, PDGF, and NF-kappa-B. These interactions make MMP24OS a promising target for small molecules and other therapeutic agents.

One of the key challenges in studying MMP24OS as a drug target is its complex cellular localization. MMP24OS is expressed in a variety of tissues and cells, and it can be difficult to selectively target it in specific cell types. However, recent studies have identified several potential strategies for improving the targeting of MMP24OS.

One approach is to use small molecules that can specifically interact with MMP24OS and enhance its expression. One example of such a small molecule is NEDD8, which is a non-coding RNA molecule that has been shown to interact with MMP24OS and increase its expression. NEDD8 has been shown to play a role in several cellular processes, including cell adhesion, migration, and invasion.

Another approach to studying MMP24OS as a drug target is to use drugs that specifically target its interactions with other proteins. One example of such a drug is rapamycin, which is an inhibitor of the mTOR pathway. The mTOR pathway is a complex signaling pathway that is involved in several cellular processes, including cell growth, metabolism, and stress response. Rapamycin has been shown to inhibit the activity of the mTOR pathway, which in turn can reduce the expression of MMP24OS.

Another potential strategy for studying MMP24OS as a drug target is to use antibodies that specifically target its expression. One example of such an antibody is an anti-MMP24OS antibody, which has been shown to block the expression of MMP24OS in various cell types. This approach can be useful for studying the effects of drugs on MMP24OS expression and function.

In conclusion, MMP24OS is a protein that is expressed in various tissues throughout the body and has been shown to play a role in several cellular processes. Its potential as a drug target is currently being investigated using a variety of approaches, including small molecules and antibodies. Further research is needed to fully understand the effects of MMP24OS on cellular processes and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: MMP24 Opposite Strand

The "MMP24OS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMP24OS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets